$80.20▼ 0.13 (0.16%)
Real-time prices · US MarketsEarnings growing 17% year-over-year on 10% revenue growth.
Quality
6.4
Health
7
Growth
7.9
Valuation
7.7
Sentiment
6.7
Analyst Target
$98.00
▲ +22.2% from current
Price Chart
Latest News
Fundamentals
Trailing P/E
21.5×
price-to-earnings
Forward P/E
12.5×
next 12 months est.
Market Cap
$103.0B
market capitalization
Div Yield
3.59%
dividend yield
Profit Margin
13.2%
net profit margin
Gross Margin
65.4%
revenue minus COGS
ROE
9.9%
return on equity
Beta
0.60
vs S&P 500
52-Week Range
$73 — $106
annual min — max
EPS — Estimate vs Actual
Frequently Asked Questions
What do analysts say about Medtronic plc. right now?
Medtronic plc.'s Q·Score is 7.1/10 (Bullish), reflecting its current fundamentals, analyst data, and valuation metrics. Earnings growing 17% year-over-year on 10% revenue growth. This is an informational data summary only and does not constitute financial advice. Always do your own research before making any investment decision.
What is the analyst price target for MDT?
The consensus price target for MDT is $98.00, based on ratings from 26 Wall Street analysts. This is 22.2% above the current price of $80.20. Price targets are forward-looking estimates and not guarantees of future performance.
Is MDT overvalued or undervalued?
Medtronic plc. (MDT) scores favorably on valuation metrics relative to sector peers and analyst targets. Its forward P/E ratio stands at 12.5×. The consensus analyst price target of $98.00 is 22% above the current price.
When does Medtronic plc. report its next earnings?
Medtronic plc.'s next earnings report is expected on approximately August 18, 2026.
What is Medtronic plc.'s profit margin?
Medtronic plc. has a net profit margin of 13.2%, which is solid for most industries. Its gross margin stands at 65.4%, indicating a high-margin business model.
What is MDT's dividend yield?
Medtronic plc. currently offers a dividend yield of 3.59%, which is above the typical market average dividend yield. Dividend yields can change based on price movements and company payout decisions.
Is Medtronic plc.'s revenue growing?
Medtronic plc. is reporting modest revenue growth of 9.9%. Earnings are also growing at 17.1%, indicating improving profitability.
How much debt does Medtronic plc. have?
Medtronic plc. has a debt-to-equity ratio of 0.57×, reflecting a moderate debt level, which is manageable for most profitable companies.
Compare MDT with any stock